Industry News and Insights

February 4, 2021 / Press Release

Avitide, Inc. the industry leader in the discovery and development of affinity purification chromatography resins, announced that it has finalized the development of an affinity bioprocess resin for the purification of recombinant COVID-19 vaccines. The AVIPure®-COV2S resin delivers outstanding performance as a capture resin for the majority of recombinant COVID-19 vaccines.

January 13, 2020 / Press Release

Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan. Under the terms of the agreement, Avitide will use its proprietary affinity chromatography discovery, development, and supply platform for programs defined by Allergan.

December 9, 2019 / Press Release

Avitide, Inc., the industry leader in the discovery and development of custom affinity purification resins, announces that it has entered into an exclusive license agreement to support the development of one of Gemini Therapeutics’ therapeutic programs.

16 Cavendish Court
Lebanon, NH 03766

603.965.2100
email us

Privacy Policy

Terms of Use

© 2021 Avitide

All Rights Reserved

Subscribe to hear the latest news and insights…